Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
OcugenOCGN |
-$5.5M |
 |
Gilead SciencesGILD |
-$4.04B |
 |
AmgenAMGN |
-$189M |
 |
Editas MedicineEDIT |
-$7M |
 |
Crispr TherapeuticsCRSP |
-$171M |
Are Sensei Biotherapeutics Insiders Buying or Selling?
Sensei Biotherapeutics (SNSE) has had no reported insider transactions in the past 90 days. The most recent was BRIAN STEPHENSON, who bought 4,212 shares at $24.90 on June 26, 2026.
Insider trading patterns can signal confidence or concern from the people who know the company best. AltIndex tracks insider transactions as one of 25+ alternative data signals in the SNSE AI Score. For government officials trading this stock, see SNSE congressional trading.
Who’s Trading Sensei Biotherapeutics Stock?
| Insider | Activity | Trades | Last Trade |
|---|---|---|---|
| ISRAEL ENGLANDER | Bought $1.3M | 49 | Apr 7, 2026 |
| BRIAN STEPHENSON | Bought $800,000 | 15 | Jun 26, 2026 |
| James Peyer | Sold $790,000 | 10 | Jun 1, 2026 |
| Cambrian BioPharma Inc | Sold $790,000 | 10 | Jun 1, 2026 |
| Parikh Anand Kiran | Bought $55,000 | 1 | Jun 22, 2026 |
Recent Sensei Biotherapeutics Insider Transactions
| Insider | Transaction Date | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| BRIAN STEPHENSON | Jun 26, 2026 | Buy | 4,212 | $24.9 | $100,000 |
| BRIAN STEPHENSON | Jun 26, 2026 | Buy | 1,358 | $25.55 | $35,000 |
| BRIAN STEPHENSON | Jun 26, 2026 | Buy | 580 | $23.61 | $14,000 |
| BRIAN STEPHENSON | Jun 26, 2026 | Buy | 100 | $26.39 | $2,600 |
| BRIAN STEPHENSON | Jun 24, 2026 | Buy | 3,400 | $26.98 | $92,000 |
| BRIAN STEPHENSON | Jun 24, 2026 | Buy | 3,000 | $25.98 | $78,000 |
| BRIAN STEPHENSON | Jun 24, 2026 | Buy | 2,891 | $25.22 | $73,000 |
| BRIAN STEPHENSON | Jun 23, 2026 | Buy | 6,836 | $24.12 | $160,000 |
| BRIAN STEPHENSON | Jun 23, 2026 | Buy | 1,969 | $24.84 | $49,000 |
| BRIAN STEPHENSON | Jun 23, 2026 | Buy | 425 | $25.91 | $11,000 |
| Parikh Anand Kiran | Jun 22, 2026 | Buy | 2,806 | $19.76 | $55,000 |
| BRIAN STEPHENSON | Jun 22, 2026 | Buy | 3,329 | $23.28 | $77,000 |
| BRIAN STEPHENSON | Jun 22, 2026 | Buy | 1,797 | $20.23 | $36,000 |
| BRIAN STEPHENSON | Jun 22, 2026 | Buy | 1,583 | $22.4 | $35,000 |
| BRIAN STEPHENSON | Jun 22, 2026 | Buy | 1,118 | $20.82 | $23,000 |
| BRIAN STEPHENSON | Jun 22, 2026 | Buy | 356 | $23.95 | $8,500 |
| Cambrian BioPharma Inc | Jun 1, 2026 | Sell | 24,524 | $20 | $490,000 |
| James Peyer | Jun 1, 2026 | Sell | 24,524 | $20 | $490,000 |
| Cambrian BioPharma Inc | Jun 1, 2026 | Sell | 476 | $21.14 | $10,000 |
| James Peyer | Jun 1, 2026 | Sell | 476 | $21.14 | $10,000 |
| ISRAEL ENGLANDER | Apr 7, 2026 | Sell | 4,423 | $31.38 | $140,000 |
| ISRAEL ENGLANDER | Apr 7, 2026 | Sell | 2,115 | $28.94 | $61,000 |
| ISRAEL ENGLANDER | Apr 7, 2026 | Sell | 1,108 | $33.38 | $37,000 |
| ISRAEL ENGLANDER | Apr 7, 2026 | Sell | 300 | $32.25 | $9,700 |
| ISRAEL ENGLANDER | Apr 7, 2026 | Sell | 205 | $29.71 | $6,100 |
| ISRAEL ENGLANDER | Apr 6, 2026 | Sell | 1,214 | $31.02 | $38,000 |
| ISRAEL ENGLANDER | Apr 6, 2026 | Buy | 1,104 | $31.02 | $34,000 |
| ISRAEL ENGLANDER | Apr 6, 2026 | Sell | 45 | $31.96 | $1,400 |
| ISRAEL ENGLANDER | Apr 2, 2026 | Sell | 3,099 | $30.86 | $96,000 |
| ISRAEL ENGLANDER | Apr 2, 2026 | Sell | 1,794 | $32.6 | $58,000 |
| ISRAEL ENGLANDER | Apr 2, 2026 | Buy | 1,276 | $34.75 | $44,000 |
| ISRAEL ENGLANDER | Apr 2, 2026 | Sell | 1,265 | $31.75 | $40,000 |
| ISRAEL ENGLANDER | Apr 2, 2026 | Sell | 1,134 | $34.8 | $39,000 |
| ISRAEL ENGLANDER | Apr 2, 2026 | Buy | 701 | $35.55 | $25,000 |
| ISRAEL ENGLANDER | Apr 2, 2026 | Sell | 374 | $33.35 | $12,000 |
| ISRAEL ENGLANDER | Apr 2, 2026 | Buy | 26 | $33.47 | $870 |
| ISRAEL ENGLANDER | Apr 1, 2026 | Buy | 3,401 | $35.46 | $120,000 |
| ISRAEL ENGLANDER | Apr 1, 2026 | Buy | 1,613 | $34.59 | $56,000 |
| ISRAEL ENGLANDER | Apr 1, 2026 | Buy | 1,161 | $31.53 | $37,000 |
| ISRAEL ENGLANDER | Apr 1, 2026 | Sell | 1,104 | $31.52 | $35,000 |
| ISRAEL ENGLANDER | Apr 1, 2026 | Sell | 46 | $34.75 | $1,600 |
| ISRAEL ENGLANDER | Mar 31, 2026 | Buy | 1,957 | $31.45 | $62,000 |
| ISRAEL ENGLANDER | Mar 31, 2026 | Buy | 1,770 | $25.32 | $45,000 |
| ISRAEL ENGLANDER | Mar 31, 2026 | Sell | 1,251 | $25.17 | $31,000 |
| ISRAEL ENGLANDER | Mar 31, 2026 | Buy | 1,048 | $26.73 | $28,000 |
| ISRAEL ENGLANDER | Mar 31, 2026 | Buy | 616 | $24.69 | $15,000 |
| ISRAEL ENGLANDER | Mar 31, 2026 | Buy | 411 | $32.6 | $13,000 |
| ISRAEL ENGLANDER | Mar 31, 2026 | Sell | 191 | $24.28 | $4,600 |
| ISRAEL ENGLANDER | Mar 31, 2026 | Buy | 186 | $30.48 | $5,700 |
| ISRAEL ENGLANDER | Mar 31, 2026 | Sell | 87 | $31.52 | $2,700 |
| ISRAEL ENGLANDER | Mar 31, 2026 | Sell | 57 | $27.11 | $1,500 |
| ISRAEL ENGLANDER | Mar 31, 2026 | Buy | 17 | $27.78 | $470 |
| ISRAEL ENGLANDER | Mar 31, 2026 | Sell | 5 | $28.41 | $140 |
| ISRAEL ENGLANDER | Mar 30, 2026 | Buy | 4,995 | $25.99 | $130,000 |
| ISRAEL ENGLANDER | Mar 30, 2026 | Buy | 2,992 | $25.08 | $75,000 |
| ISRAEL ENGLANDER | Mar 30, 2026 | Buy | 1,176 | $26.7 | $31,000 |
| ISRAEL ENGLANDER | Mar 30, 2026 | Sell | 518 | $25.85 | $13,000 |
| ISRAEL ENGLANDER | Mar 30, 2026 | Sell | 370 | $27.68 | $10,000 |
| ISRAEL ENGLANDER | Mar 27, 2026 | Buy | 10,643 | $26.29 | $280,000 |
| ISRAEL ENGLANDER | Mar 27, 2026 | Buy | 4,384 | $27.28 | $120,000 |
| ISRAEL ENGLANDER | Mar 27, 2026 | Sell | 469 | $26.77 | $13,000 |
| ISRAEL ENGLANDER | Mar 27, 2026 | Buy | 294 | $28.13 | $8,300 |
| ISRAEL ENGLANDER | Mar 27, 2026 | Sell | 36 | $27.37 | $990 |
| ISRAEL ENGLANDER | Mar 26, 2026 | Buy | 2,601 | $28.85 | $75,000 |
| ISRAEL ENGLANDER | Mar 26, 2026 | Buy | 1,327 | $27.95 | $37,000 |
| ISRAEL ENGLANDER | Mar 26, 2026 | Sell | 1,274 | $28.69 | $37,000 |
| ISRAEL ENGLANDER | Mar 26, 2026 | Buy | 1,025 | $29.98 | $31,000 |
| ISRAEL ENGLANDER | Mar 26, 2026 | Buy | 778 | $27.23 | $21,000 |
| ISRAEL ENGLANDER | Mar 26, 2026 | Sell | 583 | $26.88 | $16,000 |
| Cambrian BioPharma Inc | Dec 9, 2025 | Sell | 3,105 | $8.59 | $27,000 |
| Cambrian BioPharma Inc | Dec 9, 2025 | Sell | 2,666 | $7.95 | $21,000 |
| James Peyer | Dec 9, 2025 | Sell | 2,666 | $7.95 | $21,000 |
| Cambrian BioPharma Inc | Dec 9, 2025 | Sell | 446 | $7.92 | $3,500 |
| Cambrian BioPharma Inc | Dec 9, 2025 | Sell | 395 | $8.04 | $3,200 |
| James Peyer | Dec 9, 2025 | Sell | 446 | $7.92 | $3,500 |
| James Peyer | Dec 9, 2025 | Sell | 395 | $8.04 | $3,200 |
| James Peyer | Dec 8, 2025 | Sell | 3,105 | $8.59 | $27,000 |
| Cambrian BioPharma Inc | Dec 5, 2025 | Sell | 14,508 | $11.4 | $170,000 |
| James Peyer | Dec 5, 2025 | Sell | 14,508 | $11.4 | $170,000 |
| Cambrian BioPharma Inc | Dec 5, 2025 | Sell | 1,745 | $12.29 | $21,000 |
| James Peyer | Dec 5, 2025 | Sell | 1,745 | $12.29 | $21,000 |
| Cambrian BioPharma Inc | Dec 5, 2025 | Sell | 42 | $13.16 | $550 |
| James Peyer | Dec 5, 2025 | Sell | 42 | $13.16 | $550 |
| Cambrian BioPharma Inc | Dec 4, 2025 | Sell | 5,000 | $9.06 | $45,000 |
| James Peyer | Dec 4, 2025 | Sell | 5,000 | $9.06 | $45,000 |
Frequently Asked Questions: Sensei Biotherapeutics Insider Trading
Sensei Biotherapeutics insiders have not reported any transactions in the past 90 days.
The most recent sale was by Cambrian BioPharma Inc who sold 24,524 shares on June 1, 2026. View all transactions in the table on this page.
Insider buying is generally a stronger signal than insider selling, since insiders may sell for personal reasons (diversification, taxes) but typically buy only when they believe the stock is undervalued. AltIndex uses insider transaction patterns alongside 25+ other signals in the AI Score.
ENGLANDER ISRAEL A has bought the most SNSE stock in the last 2 years, with a total value of $1.3M.
Peyer James has sold the most SNSE stock in the last 2 years, with a total value of $790,000.
The total value of insider transactions for Sensei Biotherapeutics in the last 2 years is negative, amounting to -$130,000. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
